Aventis to sell research center in France to subsidiary of DuPont

Article Abstract:

Aventis SA will sell off a major research center in France to a DuPont Co. subsidiary. The sale is part of Aventis' integration program.

Facilities & equipment, Research and Testing Services, Scientific Research and Development Services, R&D Facilities, High technology industry, Buildings and facilities, E.I. du Pont de Nemours and Co., Aventis S.A., Laboratories

---

For Glaxo SmithKline, getting to the altar was just a beginning

Article Abstract:

The 44.16 billion pounds (71.16 billion euros) merger between Glaxo Wellcome PLC and SmithKline Beecham PLC forms the largest drug maker in the world. However, the painstaking merger negotiations only presaged a series of challenges for the merged entity.

United Kingdom, Glaxo Wellcome PLC, SmithKline Beecham PLC

---

Sanofi and Synthelabo agree to merge forming a top 20 global drug maker

Article Abstract:

French pharmaceutical companies Synthelabo S.A. and Sanofi S.A. have announced their intention to merge. The new business, called Sanofi-Synthelabo, will become the sixth largest pharmacuetical firm in Europe. Annual sales are predicted to reach $6.2 billion.

Comment:

French pharmaceutical companies Synthelabo S.A. and Sanofi S.A. have announced their intention to merge.

Abstract, Sanofi S.A., Synthelabo S.A.

Similar abstracts:

• Abstracts: San Miguel agrees to reacquire Philippine Coke-bottling business. Granada Group, Seven Network sign joint-venture deal
• Abstracts: Nissan reports six-month loss; Renault pushes to revamp car maker. Nissan keeps pay-cut option in bid to slash labor costs
• Abstracts: France Telecom, Deutsche Telekom explore selling stakes in Sprint. Deutsche Telekom talks in U.S. are heating up
• Abstracts: E-commerce gets hard cell; mobile phone is poised to dominate Internet transactions in the region. Global Tech shifts to a retail strategy
• Abstracts: Newmont Gold -mine closure blocked by Supreme Court. (Indonesia's Supreme Court). Geologist doubt fraud in Bre-X's Busang find

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.